The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice

European Journal of Pharmacology

Volumn 499, Issue 3, 2004, Pages 285-290

  Blagaic, Alenka Boban ^a   Blagaic, Vladimir ^a   Romic, Zeljko ^a   Sikiric, Predrag ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Acute alcohol intoxication; Stable gastric pentadecapeptide BPC 157; Withdrawal chronic alcohol consumption

Indexed keywords

ALCOHOL; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYL ALANYLGLYCYLLEUCYLVALINE; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALANYLGLYCYLLEUCYLVALINE; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ALCOHOL BLOOD LEVEL; ALCOHOL INTOXICATION; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRINKING BEHAVIOR; HYPOTHERMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ALCOHOL WITHDRAWAL SEIZURES; ALCOHOLISM; ANIMALS; ANTI-ULCER AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED STRAINS; PEPTIDE FRAGMENTS; PROTEINS; STOMACH; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 4544366244     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.07.112     Document Type: Article

References (21)

1. M.L. Adams, and T.J. Cicero Alcohol intoxication and withdrawal: the role of nitric oxide Alcohol 16 1998 153 158
2. M. Egli Peptides: their role in excess alcohol drinking and their promise as therapeutic tool Physiol. Behav. 79 2003 89 93
3. F. Fadda, and Z.I. Rossetti Chronic ethanol consumption: from neuroadaptation to neurodegeneration Prog. Neurobiol. 56 1998 385 431
4. J.R. Grogan, and M.S. Kochar Alcohol and hypertension Arch. Fam. Med. 3 1994 150 154
5. N. Jelovac, P. Sikiric, R. Rucman, M. Petek, D. Perovic, P. Konjevoda, A. Marovic, S. Seiwerth, Z. Grabarevic, J. Sumajstorcic, G. Dodig, and J. Peric A novel pentadecapeptide, BPC 157, blocks the stereotypy produced acutely by amphetamine and the development of haloperidol-induced supersensitivity to amphetamine Biol. Psychiatry 43 1998 511 519
6. N. Jelovac, P. Sikiric, R. Rucman, M. Petek, A. Marovic, D. Perovic, S. Seiwerth, S. Mise, B. Turkovic, G. Dodig, P. Miklic, G. Buljat, and I. Prkacin Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats Eur. J. Pharmacol. 379 1999 19 31
7. G. Koob, and F.E. Bloom Memory, learning and adaptive behaviours D.T. Krieger M.J. Browstein J.B. Martin Brain Peptides 1983 Wiley New York 369 388
8. M. Lovric-Bencic, P. Sikiric, J. Separovic, S. Seiwerth, D. Rogic, V. Kusec, G. Aralica, P. Konjevoda, L. Batelja, and A. Boban Blagaic Doxorubicine congestive heart failure-increased big-endothelin 1 plasma concentration. Reversal by amlodipine, losartan and gastric pentadecapeptide BPC 157 in rat and mouse J. Pharmacol. Sci. 95 2004 19 26
9. B. Malinowska, D. Napiorkowska-Pawlak, R. Pawlak, W. Buczko, and M. Gothert Ifenprodil influences changes in mouse behavior related to acute and chronic ethanol administration Eur. J. Pharmacol. 377 1999 13 19
10. J. McKinley, and B.J. Olfield The brain as an endocrine target for peptide hormones TEM 9 1998 349 353
11. I. Prkacin, G. Aralica, D. Perovic, J. Separovic, M. Gjurasin, M. Lovric-Bencic, D. Stancic-Rokotov, T. Ziger, T. Anic, P. Sikiric, S. Seiwerth, M. Staresinic, S. Mise, I. Rotkvic, V. Jagic, R. Rucman, M. Petek, B. Turkovic, A. Marovic, A. Boban-Blagaic, and Z. Ivasovic Chronic cytoprotection: pentadecapeptide BPC 157, ranitidine and propranolol prevent, attenuate and reverse the gastric lesions appearance in chronic alcohol drinking rats J. Physiol. (Paris) 95 2001 295 301
12. I. Prkacin, J. Separovic, G. Aralica, D. Perovic, M. Gjurasin, M. Lovric-Bencic, D. Stancic-Rokotov, M. Staresinic, T. Anic, D. Mikus, P. Sikiric, S. Seiwerth, S. Mise, I. Rotkvic, V. Jagic, R. Rucman, M. Petek, B. Turkovic, A. Marovic, B. Sebecic, A. Boban-Blagaic, and N. Kokic Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol, but not ranitidine J. Physiol. (Paris) 95 2001 315 324
13. I. Prkacin, M. Staresinic, S. Suknaic, J. Separovic, D. Stancic Rokotov, G. Aralica, A. Boban Blagaic, D. Perovic, R. Rucman, M. Petek, T. Anic, S. Seiwerth, and P. Sikiric Reduction of Doppler shift of otherwise increased blood flow velocity in v. cava inferior and v. portae of chronically alcohol drinking portal hypertensive rats by gastric pentadecapeptide BPC 157 (PL-10) Gastroenterology 122 2002 353
14. P. Sikiric, S. Seiwerth, Z. Grabarevic, M. Petek, R. Rucman, B. Turkovic, I. Rotkvic, V. Jagic, M. Duvnjak, and S. Mise The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesion induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promoters and gut peptides Life Sci. 54 1994 PL63 PL68
15. G-nitro-l-arginine methylester and l-arginine effect on stomach mucosal integrity and blood pressure Eur. J. Pharmacol. 332 1997 23 33
16. P. Sikiric, A. Marovic, W. Matoz, T. Anic, G. Buljat, D. Mikus, D. Stancic-Rokotov, J. Separovic, S. Seiwerth, Z. Grabarevic, R. Rucman, M. Petek, T. Ziger, B. Sebecic, I. Zoricic, B. Turkovic, G. Aralica, D. Perovic, B. Duplancic, M. Lovric-Bencic, I. Rotkvic, S. Mise, V. Jagic, and V. Hahn A behavioral study of the effect of pentadecapeptide BPC 157 in Parkinson’s disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropropyridine J. Physiol. (Paris) 93 1999 505 512
17. P. Sikiric, N. Jelovac, A. Jelovac Gjeldum, G. Dodig, M. Staresinic, T. Anic, I. Zoricic, D. Perovic, G. Aralica, G. Buljat, I. Prkacin, M. Lovric-Bencic, J. Separovic, S. Seiwerth, R. Rucman, M. Petek, B. Turkovic, and T. Ziger Anxiolytic effect of BPC 157, a gastric pentadecapeptide: shock probe/burying test and light/dark test Acta Pharmacol. Sin. 22 2001 225 230
18. P. Sikiric, N. Jelovac, A. Gjeldum, G. Dodig, M. Staresinic, T. Anic, I. Zoricic, D. Rak, G. Aralica, G. Buljat, I. Prkacin, M. Lovric-Bencic, J. Separovic, S. Seiwerth, R. Rucman, M. Petek, B. Turkovic, T. Ziger, A. Boban-Blagaic, V. Bedekovic, A. Tonkic, and S. Babic Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances Acta Pharmacol. Sin. 23 2002 412 422
19. S. Szabo, J.S. Trier, A. Brown, and J. Schnoor Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat Gastroenterology 88 1985 228 236
20. M. Veljaca, K. Chan, and A. Guglietta Digestion of h-EGF, h-TGF alpha and BPC-15 in human gastric juice Gastroenterology 108 1995 761
21. Veljaca, M., Krnic, Z., Brajsa, K., Mildner, B., Pavic-Sladojev, D., Seveljevic-Jaran, D., Kolega, M., Erceg, D., Krznaric, Z., 2002. The development of PL 14736 for treatment of inflammatory bowel disease. IUPHAR-GI Section Symposium, Honolulu, Hawaii, 13-15, O-32.